High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma

This publication has 10 references indexed in Scilit:

• The Use of β-Agonists and the Risk of Death and near Death from Asthma
  New England Journal of Medicine, 1992
• Bone turnover during high dose inhaled corticosteroid treatment.
  Thorax, 1991
• Regular inhaled beta-agonist treatment in bronchial asthma
  The Lancet, 1990
• A comparison of inhaled beclomethasone dipropionateand nedocromil sodium as additional therapy in asthma
  Respiratory Medicine, 1990
• Purpura and dermal thinning associated with high dose inhaled corticosteroids.
  BMJ, 1990
• A 3-month evaluation of the efficacy of nedocromil sodium in asthma: A randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group
  Journal of Allergy and Clinical Immunology, 1990
• Effects of adding nedocromil sodium (TiladeR) to the routine therapy of patients with bronchial asthma
  Clinical and Experimental Allergy, 1989
• Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study.
  Thorax, 1989
• Effectiveness of Nedocromil Sodium versus Placebo as Additions to Routine Asthma Maintenance Therapy: a Multicentre, Double-Blind, Group Comparative Trial
  Respiration, 1989
• Damage of the Airway Epithelium and Bronchial Reactivity in Patients with Asthma
  American Review of Respiratory Disease, 1985